Pharmacological profile of T-1032, a novel specific phosphodiesterase type 5 inhibitor, in isolated rat aorta and rabbit corpus cavernosum

By Takagi M.   Mochida H.   Noto T.   Yano K.   Inoue H.   Ikeo T.   Kikkawa K.  

European Journal of Pharmacology, Vol. 411, Iss. 1, 2001-05 ,pp. : 161-168

Elsevier

Access to resources Recommend Favorite

Sildenafil and T-1032, phosphodiesterase type 5 inhibitors, showed a different vasorelaxant property in the isolated rat aorta

By Mochida H.   Inoue H.   Takagi M.   Noto T.   Yano K.   Kikkawa K.  

European Journal of Pharmacology, Vol. 440, Iss. 1, 2002-04 ,pp. : 45-52

Elsevier

Access to resources Recommend Favorite

Vardenafil: a novel type 5 phosphodiesterase inhibitor for the treatment of erectile dysfunction

By Kendirci Muammer   Bivalacqua Trinity J   Hellstrom Wayne JG  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 4, 2004-04 ,pp. : 923-932

Informa Healthcare

Access to resources Recommend Favorite

Characterization of a novel phosphodiesterase type 5 inhibitor: JNJ-10258859

By Qiu Y.   Bhattacharjee S.   Kraft P.   John T.M.   Craig E.   Haynes-Johnson D.   Guan J.   Jiang W.   Macielag M.   Sui Z.   Clancy J.   Lundeen S.  

European Journal of Pharmacology, Vol. 472, Iss. 1, 2003-07 ,pp. : 73-80

Elsevier

Access to resources Recommend Favorite

Potency and selectivity of vardenafil: a phosphodiesterase Type 5 inhibitor

By Sommer Frank  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 1, Iss. 2, 2005-08 ,pp. : 295-301

Informa Healthcare

Access to resources Recommend Favorite